Feb 09, 2021
Catalent Launches CosmoPod® Duo - New Dual Chamber Capsule for Beauty and Consumer Health Topical Applications
Feb 08, 2021
Catalent Signs Development and Manufacturing Agreement with Trizell for Macrophage-based Advanced Cell Therapy
Dec 09, 2020
Catalent Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan
Oct 19, 2020
Catalent Launches OptiGel® DR, a Delayed/Enteric Release Softgel for Pharmaceutical and Nutraceutical Applications
Sep 28, 2020
Catalent Supports Rapid Development and Supply of Nocion Therapeutics' Clinical Trial Materials for Acute and Chronic Cough Using Blow-Fill-Seal Technology
Sep 22, 2020
Advantages of Oncolytic Viruses as Immunotherapies to be Discussed by Catalent Gene Therapy Expert at World Vaccine Congress
Sep 15, 2020
Modern Clinical Supply Strategies and Ensuring Effective Solutions to be Discussed by Catalent Experts at GCSG Virtual
Sep 02, 2020
Catalent Biologics Invests $50 Million to Add Third High-Speed Vial Line at its Bloomington, Indiana, Facility
Aug 18, 2020
Catalent to Discuss a Scalable Gene Therapy Manufacturing Process and Early Development Considerations for Orphan Drugs at Upcoming Industry Congress
Aug 06, 2020
Catalent Gene Therapy Facility Receives FDA Approval as an Additional Manufacturing Site for AveXis' Gene Therapy
Aug 04, 2020
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
Jul 22, 2020
Catalent Biologics' Executive to Discuss Manufacturing Scale-up During a Pandemic
Jul 01, 2020
Catalent Completes Purchase of Pharmaceutical Packaging Facility in Shiga, Japan
Jun 24, 2020
Catalent to Discuss Data-Driven Approaches for Small Molecule Drug Development at the Controlled Release Society Annual Meeting
Jun 22, 2020
Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19
Jun 11, 2020
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
Jun 11, 2020
Catalent, Inc. Announces Public Offering of Common Stock
Jun 09, 2020
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast to Reach USD 224.9 Billion by 2025, Registering a CAGR of 7%, During the Period of 2020-2025
Jun 02, 2020
Catalent Appoints Charles Lickfold as Chief Information Officer
May 29, 2020
Catalent, Inc. to Present at June 2020 Virtual Investor Conferences